NCT01052610

Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites

Assessment of Effectiveness and Safety of Annual Sublingual Immunotherapy in Children With Bronchial Asthma and/or Allergic Rhinitis Allergic to House Dust Mites

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Medical University of Lodz · Academic / Other
• Sex: All
• Age: 6 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the trial is to asses the efficacy and safety of sublingual annual immunotherapy in children with bronchial asthma and/or allergic rhinitis allergic to house dust mites.

Detailed description

Allergen immunotherapy is currently the only one method of cause treatment of the IgE-dependent allergic diseases. Sublingual immunotherapy (SLIT) is the method which allows to give allergens via alternative oral route in patients home. Due to possibility of avoiding injection this therapy offers better relationship with pediatric patient. However efficacy and safety of sublingual immunotherapy are still important issues, especially in asthmatic children. The purpose of the trial is to asses the efficacy and safety of sublingual annual immunotherapy in children with bronchial asthma and/or allergic rhinitis allergic to house dust mites.

Conditions

• Bronchial Asthma
• Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	sublingual house dust mites allergen extract	Staloral 300 IR, Stallergenes, France
DRUG	placebo in sublingual applicator	placebo for Staloral 300 IR, Stallergenes, France

Timeline

• Start date: 2010-06-01
• Primary completion: 2013-09-01
• Completion: 2013-09-01
• First posted: 2010-01-20
• Last updated: 2013-02-07

Locations

1 site across 1 country: Poland